ADCAN Pharma, a leading UAE-based pharmaceutical manufacturer, signed a Memorandum of Understanding (MoU) with M42, a global health leader powered by artificial intelligence (AI), technology and genomics, to explore collaboration… The post ADCAN Pharma and M42 to collaborate on advanced oncology manufacturing and clinical research in the UAE appeared first on Web-Release.
Breaking News:
- On its 185th anniversary, Sber unveils its new Strategy 2029
- CNTXT AI Commits More Than AED 180 Million to Train and Deploy Physical AI
- Signing of a USD 4.5 Million Letter of Intent with OCHA, Paving the Way to Join the Donor Group
- Omar Alsuwaidi and Khaled Alshehhi Strike Black Belt Gold in a Historic Achievement at Abu Dhabi World Professional Jiu-Jitsu Championship
- Celebrate Christmas Day with a Magical Garden Brunch at Al Habtoor Grand Resort
- Hamdan Bin Mohammed Smart University Examines Harvard, MIT and Boston University’s Approaches to University Endowments and Financial Sustainability
- Burjeel Hospital Wins First Place at Emirates Labour Market Award 2026
- EGHS Conference 2026 Opens in Dubai, Bringing Together Experts from the UAE and Around the World
Sunday, November 22